Hurst L: Bacteriology. Scientific e-Resources, 2019.

Atkinson TP and Waites KB: Mycoplasma pneumoniae infections in childhood. Pediatr Infect Dis J. 33:92–94. 2014.

Kashyap S and Sarkar M: Mycoplasma pneumonia: Clinical features and management. Lung India. 27(75)2010.PubMed/NCBI View Article : Google Scholar

Li ZJ, Zhang HY, Ren LL, Lu QB, Ren X, Zhang CH, Wang YF, Lin SH, Zhang XA, Li J, et al: Etiological and epidemiological features of acute respiratory infections in China. Nat Commun. 12(5026)2021.PubMed/NCBI View Article : Google Scholar

Dumke R and Ziegler T: Long-term low rate of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Antimicrob Agents Chemother. 63:e00455–19. 2019.PubMed/NCBI View Article : Google Scholar

Baseman JB and Tully JG: Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis. 3:21–32. 1997.PubMed/NCBI View Article : Google Scholar

Waites KB and Talkington DF: Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 17:697–728. 2004.PubMed/NCBI View Article : Google Scholar

Restrepo MI and Reyes LF: Pneumonia as a cardiovascular disease. Respirology. 23:250–259. 2018.PubMed/NCBI View Article : Google Scholar

Yang J, Zhao H, Yuan H, Zhu F and Zhou W: Prevalence and association of mycoplasma infection in the development of coronary artery disease. Braz J Biol. 83(e246385)2021.PubMed/NCBI View Article : Google Scholar

Rezaee-Zavareh MS, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M and Einollahi B: Infectious and coronary artery disease. ARYA Atheroscler. 12(41)2016.PubMed/NCBI

Nazir S, Jankowski V, Bender G, Zewinger S, Rye KA and van der Vorst EPC: Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Adv Drug Deliv Rev. 159:94–119. 2020.PubMed/NCBI View Article : Google Scholar

Lee-Rueckert M, Escola-Gil JC and Kovanen PT: HDL functionality in reverse cholesterol transport-Challenges in translating data emerging from mouse models to human disease. Biochim Biophys Acta. 1861:566–583. 2016.PubMed/NCBI View Article : Google Scholar

Abd El-Aal HAHM: Lipid peroxidation end-products as a key of oxidative stress: effect of antioxidant on their production and transfer of free radicals. Submitted: 11 November 2011 Published: 29 August 2012. doi: 10.5772/45944.

Tousoulis D, Andreou I, Antoniades C, Tentolouris C and Stefanadis C: Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: Therapeutic implications for cardiovascular diseases. Atherosclerosis. 201:236–247. 2008.PubMed/NCBI View Article : Google Scholar

Adegbola P, Aderibigbe I, Hammed W and Omotayo T: Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: A review. Am J Cardiovasc Dis. 7(19)2017.PubMed/NCBI

Ouweneel AB and Van Eck M: Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation. Vascul Pharmacol. 82:1–10. 2016.PubMed/NCBI View Article : Google Scholar

Mineo C and Shaul PW: Novel biological functions of high-density lipoprotein cholesterol. Circ Res. 111:1079–1090. 2012.PubMed/NCBI View Article : Google Scholar

Wang J, Xia C, Sharma A, Gaba GS and Shabaz M: Chest CT findings and differential diagnosis of Mycoplasma pneumoniae pneumonia and Mycoplasma pneumoniae combined with streptococcal pneumonia in children. J Healthc Eng. 2021(8085530)2021.PubMed/NCBI View Article : Google Scholar

Hu J, Ye Y, Chen X, Xiong L, Xie W and Liu P: Insight into the pathogenic mechanism of Mycoplasma pneumoniae. Curr Microbiol. 80(14)2023.PubMed/NCBI View Article : Google Scholar

Jiang Z, Li S, Zhu C, Zhou R and Leung PHM: Mycoplasma pneumoniae infections: pathogenesis and vaccine development. Pathogens. 10(119)2021.PubMed/NCBI View Article : Google Scholar

Rank RG: Role of the immune response, in Microbiology of chlamydia. CRC Press. pp217-234, 2019.

Porsch F, Mallat Z and Binder CJ: Humoral immunity in atherosclerosis and myocardial infarction: From B cells to antibodies. Cardiovasc Res. 117:2544–2562. 2021.PubMed/NCBI View Article : Google Scholar

Stelmach I, Podsiadłowicz-Borzecka M, Grzelewski T, Majak P, Stelmach W, Jerzyńska J, Popławska M and Dziadek J: Humoral and cellular immunity in children with Mycoplasma pneumoniae infection: A 1-year prospective study. Clin Diagn Lab Immunol. 12:1246–1250. 2005.PubMed/NCBI View Article : Google Scholar

Nutt SL and Huntington ND: Cytotoxic T lymphocytes and natural killer cells, in Clinical Immunology. Elsevier. pp247-259.e1, 2019.

Zhu X and Zhu J: CD4 T helper cell subsets and related human immunological disorders. Int J Mol Sci. 21(8011)2020.PubMed/NCBI View Article : Google Scholar

Delves PJ and Roitt IM: The immune system. First of two parts. N Engl J Med. 343:37–49. 2000.PubMed/NCBI View Article : Google Scholar

Rich RR and Chaplin DD: The human immune response, in Clinical Immunology. Elsevier. pp3-17.e1, 2019.

Parija SC: Immune response, in Textbook of Microbiology and Immunology. Springer. pp211-226, 2023.

Takatsu K: Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med. 215:121–133. 1997.PubMed/NCBI View Article : Google Scholar

de Araújo-Souza PS, Hanschke SC and Viola JP: Epigenetic control of interferon-gamma expression in CD8 T cells. J Immunol Res. 2015(849573)2015.PubMed/NCBI View Article : Google Scholar

Mendoza L: A network model for the control of the differentiation process in Th cells. Biosystems. 84:101–114. 2006.PubMed/NCBI View Article : Google Scholar

Pan W, Wang Q and Chen Q: The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 11(30)2019.PubMed/NCBI View Article : Google Scholar

Yang J, Hooper WC, Phillips DJ and Talkington DF: Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev. 15:157–168. 2004.PubMed/NCBI View Article : Google Scholar

Sahu SK, Kulkarni DH, Ozanturk AN, Ma L and Kulkarni HS: Emerging roles of the complement system in host-pathogen interactions. Trends Microbiol. 30:390–402. 2022.PubMed/NCBI View Article : Google Scholar

Noris M and Remuzzi G: Overview of complement activation and regulation. Semin Nephrol. 33:479–492. 2013.PubMed/NCBI View Article : Google Scholar

He J, Liu M, Ye Z, Tan T, Liu X, You X, Zeng Y and Wu Y: Insights into the pathogenesis of Mycoplasma pneumoniae (Review). Mol Med Rep. 14:4030–4036. 2016.PubMed/NCBI View Article : Google Scholar

Esposito S, Argentiero A, Gramegna A and Principi N: Mycoplasma pneumoniae: A pathogen with unsolved therapeutic problems. Expert Opin Pharmacother. 22:1193–1202. 2021.PubMed/NCBI View Article : Google Scholar

Narita M: Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 16:162–169. 2010.PubMed/NCBI View Article : Google Scholar

Narita M: Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol. 7(23)2016.PubMed/NCBI View Article : Google Scholar

Jomard A and Osto E: High density lipoproteins: Metabolism, function, and therapeutic potential. Front Cardiovasc Med. 7(39)2020.PubMed/NCBI View Article : Google Scholar

Xepapadaki E, Nikdima I, Sagiadinou EC, Zvintzou E and Kypreos KE: HDL and type 2 diabetes: the chicken or the egg? Diabetologia. 64:1917–1926. 2021.PubMed/NCBI View Article : Google Scholar

Ben-Aicha S, Badimon L and Vilahur G: Advances in HDL: Much more than lipid transporters. Int J Mol Sci. 21(732)2020.PubMed/NCBI View Article : Google Scholar

Ganjali S, Banach M, Pirro M, Fras Z and Sahebkar A: HDL and cancer-causality still needs to be confirmed? Update 2020. Semin Cancer Biol. 73:169–177. 2021.PubMed/NCBI View Article : Google Scholar

Chan DC: Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol. 15:235–259. 2020.PubMed/NCBI View Article : Google Scholar

Zheng A, Li H, Feng Z and Liu J: Integrative analyses reveal Tstd1 as a potential modulator of HDL cholesterol and mitochondrial function in mice. Cells. 10(2976)2021.PubMed/NCBI View Article : Google Scholar

Lu Y, Li B, Wei M, Zhu Q, Gao L, Ma N, Ma X, Yang Q, Tong Z, Lu G and Li W: HDL inhibits pancreatic acinar cell NLRP3 inflammasome activation and protect against acinar cell pyroptosis in acute pancreatitis. Int Immunopharmacol. 125(110950)2023.PubMed/NCBI View Article : Google Scholar

Wei Y, Lan B, Zheng T, Yang L, Zhang X, Cheng L, Tuerhongjiang G, Yuan Z and Wu Y: GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis. Nat Commun. 14(929)2023.PubMed/NCBI View Article : Google Scholar

Webb NR: High-density lipoproteins and serum amyloid A (SAA). Curr Atheroscler Rep. 23(7)2021.PubMed/NCBI View Article : Google Scholar

Malle E and De Beer FC: Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 26:427–435. 1996.PubMed/NCBI View Article : Google Scholar

Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M and Sahebkar A: Effects of curcumin on HDL functionality. Pharmacol Res. 119:208–218. 2017.PubMed/NCBI View Article : Google Scholar

Bonacina F, Pirillo A, Catapano AL and Norata GD: HDL In immune-inflammatory responses: Implications beyond cardiovascular diseases. Cells. 10(1061)2021.PubMed/NCBI View Article : Google Scholar

Szabo G, Romics L Jr and Frendl G: Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 6:1045–1066. 2002.PubMed/NCBI View Article : Google Scholar

von Eckardstein A, Nordestgaard BG, Remaley AT and Catapano AL: High-density lipoprotein revisited: Biological functions and clinical relevance. Eur Heart J. 44:1394–1407. 2023.PubMed/NCBI View Article : Google Scholar

Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR and Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res. 45:1169–1196. 2004.PubMed/NCBI View Article : Google Scholar

Luo H, He J, Qin L, Chen Y, Chen L, Li R, Zeng Y, Zhu C, You X and Wu Y: Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response. Clin Exp Immunol. 203:66–79. 2021.PubMed/NCBI View Article : Google Scholar

Ramos EI, Das K, Harrison AL, Garcia A, Gadad SS and Dhandayuthapani S: Mycoplasma genitalium and M. pneumoniae regulate a distinct set of protein-coding genes in epithelial cells. Front Immunol. 12(738431)2021.PubMed/NCBI View Article : Google Scholar

Felder KM, Carranza PM, Gehrig PM, Roschitzki B, Barkow-Oesterreicher S, Hoelzle K, Riedel K, Kube M and Hoelzle LE: Insights into the gene expression profile of uncultivable hemotrophic Mycoplasma suis during acute infection, obtained using proteome analysis. J Bacteriol. 194:1505–1514. 2012.PubMed/NCBI View Article : Google Scholar

Schmidl SR, Otto A, Lluch-Senar M, Piñol J, Busse J, Becher D and Stülke J: A trigger enzyme in Mycoplasma pneumoniae: Impact of the glycerophosphodiesterase GlpQ on virulence and gene expression. PLoS Pathog. 7(e1002263)2011.PubMed/NCBI View Article : Google Scholar

Sharma NK, Ferreira BL, Tashima AK, Brunialti MKC, Torquato RJS, Bafi A, Assuncao M, Azevedo LCP and Salomao R: Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis. Clin Proteomics. 16(29)2019.PubMed/NCBI View Article : Google Scholar

Trinder M, Genga KR, Kong HJ, Blauw LL, Lo C, Li X, Cirstea M, Wang Y, Rensen PCN, Russell JA, et al: Cholesteryl ester transfer protein influences high-density lipoprotein levels and survival in sepsis. Am J Respir Crit Care Med. 199:854–862. 2019.PubMed/NCBI View Article : Google Scholar

Adorni MP, Ronda N, Bernini F and Zimetti F: High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: Pathophysiological aspects and pharmacological perspectives. Cells. 10(574)2021.PubMed/NCBI View Article : Google Scholar

Ahn KK, Kwon D, Jung K, Ha Y, Seo MJ, Kim SH, Kim MY, Cho KD, Lee BH and Chae C: Identification of interleukin-1, tumor necrosis factor-α, and interleukin-6 expression in lungs from pigs naturally infected with Mycoplasma hyopneumoniae by in situ hybridization. J Vet Med Sci. 71:441–445. 2009.PubMed/NCBI View Article : Google Scholar

Su X, Zhang G, Cheng Y and Wang B: New insights into the emerging effects of inflammatory response on HDL particles structure and function. Mol Biol Rep. 48:5723–5733. 2021.PubMed/NCBI View Article : Google Scholar

Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D and Chin-Dusting J: High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 28:2071–2077. 2008.PubMed/NCBI View Article : Google Scholar

Udomkarnjananun S, Takkavatakarn K, Praditpornsilpa K, Nader C, Eiam-Ong S, Jaber BL and Susantitaphong P: Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis. J Nephrol. 33:343–354. 2020.PubMed/NCBI View Article : Google Scholar

Murgia F, Giagnoni F, Lorefice L, Caria P, Dettori T, D'Alterio MN, Angioni S, Hendren AJ, Caboni P, Pibiri M, et al: Sex hormones as key modulators of the immune response in multiple sclerosis: A review. Biomedicines. 10(3107)2022.PubMed/NCBI View Article : Google Scholar

Li J, Song CL, Wang T, Ye YL, Du JR, Li SH and Zhu JM: Etiological and epidemiological characteristics of severe acute respiratory infection caused by multiple viruses and Mycoplasma pneumoniae in adult patients in Jinshan, Shanghai: A pilot hospital-based surveillance study. PLoS One. 16(e0248750)2021.PubMed/NCBI View Article : Google Scholar

Blasi F: Atypical pathogens and respiratory tract infections. Eur Respir J. 24:171–182. 2004.PubMed/NCBI View Article : Google Scholar

Wang HH, Garruti G, Liu M, Portincasa P and Wang DQ: Cholesterol and lipoprotein metabolism and atherosclerosis: Recent advances in reverse cholesterol transport. Ann Hepatol. 16:27–42. 2018.

Higuchi ML, Sambiase N, Palomino S, Gutierrez P, Demarchi LM, Aiello VD and Ramires JA: Detection of Mycoplasma pneumoniae and chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res. 33:1023–1026. 2000.PubMed/NCBI View Article : Google Scholar

Kumar V: Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 11(1722)2020.PubMed/NCBI View Article : Google Scholar

Rosenson RS, Brewer HB Jr, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR and Webb NR: Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 13:48–60. 2016.PubMed/NCBI View Article : Google Scholar

Yu H: HDL and scavenger receptor class B Type I (SRBI). Adv Exp Med Biol. 1377:79–93. 2022.PubMed/NCBI View Article : Google Scholar

Esteve E, Ricart W and Fernández-Real JM: Dyslipidemia and inflammation: An evolutionary conserved mechanism. Clin Nutr. 24:16–31. 2005.PubMed/NCBI View Article : Google Scholar

Tan M, Ye J, Zhao M, Ke X, Huang K and Liu H: Recent developments in the regulation of cholesterol transport by natural molecules. Phytother Res. 35:5623–5633. 2021.PubMed/NCBI View Article : Google Scholar

Tosheska Trajkovska K and Topuzovska S: High-density lipoprotein metabolism and reverse cholesterol transport: Strategies for raising HDL cholesterol. Anatol J Cardiol. 18(149)2017.PubMed/NCBI View Article : Google Scholar

Baranova IN, Bocharov AV, Vishnyakova TG, Chen Z, Birukova AA, Ke Y, Hu X, Yuen PST, Star RA, Birukov KG, et al: Class B scavenger receptors BI and BII protect against LPS-Induced acute lung injury in mice by mediating LPS. Infect Immun. 89(e0030121)2021.PubMed/NCBI View Article : Google Scholar

Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC and van der Westhuyzen DR: SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem. 273:15241–15248. 1998.PubMed/NCBI View Article : Google Scholar

Glatz JFC and Luiken JJFP: Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization. J Lipid Res. 59:1084–1093. 2018.PubMed/NCBI View Article : Google Scholar

Catapano AL, Pirillo A, Bonacina F and Norata GD: HDL in innate and adaptive immunity. Cardiovasc Res. 103:372–383. 2014.PubMed/NCBI View Article : Google Scholar

Meyer Sauteur PM, Theiler M, Buettcher M, Seiler M, Weibel L and Berger C: Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia. JAMA Dermatol. 156:144–150. 2020.PubMed/NCBI View Article : Google Scholar

Segovia JA, Chang TH, Winter VT, Coalson JJ, Cagle MP, Pandranki L, Bose S, Baseman JB and Kannan TR: NLRP3 is a critical regulator of inflammation and innate immune cell response during Mycoplasma pneumoniae infection. Infect Immun. 86:e00548–17. 2017.PubMed/NCBI View Article : Google Scholar

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A and Nasri H: Atherosclerosis: Process, indicators, risk factors and new hopes. Int J Prev Med. 5(927)2014.PubMed/NCBI

Grao-Cruces E, Lopez-Enriquez S, Martin ME and Montserrat-de la Paz S: High-density lipoproteins and immune response: A review. Int J Biol Macromol. 195:117–123. 2022.PubMed/NCBI View Article : Google Scholar

Pirillo A, Catapano AL and Norata GD: HDL in infectious diseases and sepsis. Handb Exp Pharmacol. 224:483–508. 2015.PubMed/NCBI View Article : Google Scholar

Stasi A, Franzin R, Fiorentino M, Squiccimarro E, Castellano G and Gesualdo L: Multifaced roles of HDL in sepsis and SARS-CoV-2 infection: Renal implications. Int J Mol Sci. 22(5980)2021.PubMed/NCBI View Article : Google Scholar

Feingold KR: The bidirectional link between HDL and COVID-19 infections. J Lipid Res. 62(100067)2021.PubMed/NCBI View Article : Google Scholar

Shimamoto T, Yamamichi N, Gondo K, Takahashi Y, Takeuchi C, Wada R, Mitsushima T and Koike K: The association of Helicobacter pylori infection with serum lipid profiles: An evaluation based on a combination of meta-analysis and a propensity score-based observational approach. PLoS One. 15(e0234433)2020.PubMed/NCBI View Article : Google Scholar

Ossoli A, Pavanello C and Calabresi L: High-density lipoprotein, lecithin: Cholesterol acyltransferase, and atherosclerosis. Endocrinol Metab (Seoul). 31:223–229. 2016.PubMed/NCBI View Article : Google Scholar

Reisinger AC, Schuller M, Sourij H, Stadler JT, Hackl G, Eller P and Marsche G: Impact of sepsis on high-Density lipoprotein metabolism. Front Cell Dev Biol. 9(795460)2022.PubMed/NCBI View Article : Google Scholar

Säemann MD, Poglitsch M, Kopecky C, Haidinger M, Hörl WH and Weichhart T: The versatility of HDL: A crucial anti-inflammatory regulator. Eur J Clin Invest. 40:1131–1143. 2010.PubMed/NCBI View Article : Google Scholar

Chen L, Zhao ZW, Zeng PH, Zhou YJ and Yin WJ: Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell Cycle. 21:1121–1139. 2022.PubMed/NCBI View Article : Google Scholar

Zannis VI, Chroni A and Krieger M: Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med. 84:276–294. 2006.PubMed/NCBI View Article : Google Scholar

Jacobo-Albavera L, Domínguez-Pérez M, Medina-Leyte DJ, González-Garrido A and Villarreal-Molina T: The role of the ATP-binding cassette A1 (ABCA1) in human disease. Int J Mol Sci. 22(1593)2021.PubMed/NCBI View Article : Google Scholar

Yin K, Liao DF and Tang CK: ATP-binding membrane cassette transporter A1 (ABCA1): A possible link between inflammation and reverse cholesterol transport. Mol Med. 16:438–449. 2010.PubMed/NCBI View Article : Google Scholar

Bhattacharya S: Reactive oxygen species and cellular defense system. Free Radicals in human health and disease, pp17-29, 2015.

Lauridsen C: From oxidative stress to inflammation: Redox balance and immune system. Poult Sci. 98:4240–4246. 2019.PubMed/NCBI View Article : Google Scholar

Juan CA, Pérez de la Lastra JM, Plou FJ and Pérez-Lebeña E: The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int J Mol Sci. 22(4642)2021.PubMed/NCBI View Article : Google Scholar

Zhang X, Zhou Y, Tang H, Zhao D and Liu F: Immunosuppression reduces lung injury caused by Mycoplasma pneumoniae infection. Sci Rep. 9(7147)2019.PubMed/NCBI View Article : Google Scholar

Tabet F and Rye KA: High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond). 116:87–98. 2009.PubMed/NCBI View Article : Google Scholar

Zhang Q, Jiang Z and Xu Y: HDL and Oxidation, in HDL Metabolism and Diseases. Springer pp63-77, 2022.

Podrez EA: Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol. 37:719–725. 2010.PubMed/NCBI View Article : Google Scholar

Seidman MA, Mitchell RN and Stone JR: Pathophysiology of atherosclerosis, in Cellular and molecular pathobiology of cardiovascular disease. Elsevier pp221-237, 2014.

Lafuse WP, Wozniak DJ and Rajaram MVS: Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair. Cells. 10(51)2020.PubMed/NCBI View Article : Google Scholar

Dobaczewski M, Gonzalez-Quesada C and Frangogiannis NG: The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol. 48:504–511. 2010.PubMed/NCBI View Article : Google Scholar

Kurose H: Cardiac fibrosis and fibroblasts. Cells. 10(1716)2021.PubMed/NCBI View Article : Google Scholar

Laflamme MA and Murry CE: Heart regeneration. Nature. 473:326–335. 2011.PubMed/NCBI View Article : Google Scholar

Patel P and Karch J: Regulation of cell death in the cardiovascular system. Int Rev Cell Mol Biol. 353:153–209. 2020.PubMed/NCBI View Article : Google Scholar

European Heart Rhythm Association; Heart Rhythm Society. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, et al: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 48:e247–e346. 2006.PubMed/NCBI View Article : Google Scholar

Aaronson PI, Ward JP and Connolly MJ: The cardiovascular system at a glance. John Wiley & Sons, 2020.

Nicholls SJ and Nelson AJ: HDL and cardiovascular disease. Pathology. 51:142–147. 2019.PubMed/NCBI View Article : Google Scholar

Giammanco A, Noto D, Barbagallo CM, Nardi E, Caldarella R, Ciaccio M, Averna MR and Cefalù AB: Hyperalphalipoproteinemia and beyond: The role of HDL in cardiovascular diseases. Life. 11(581)2021.PubMed/NCBI View Article : Google Scholar

Rohatgi A, Westerterp M, von Eckardstein A, Remaley A and Rye KA: HDL in the 21st century: A multifunctional roadmap for future HDL research. Circulation. 143:2293–2309. 2021.PubMed/NCBI View Article : Google Scholar

Lee KY: Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther. 6:509–521. 2008.PubMed/NCBI View Article : Google Scholar

Pothineni NVK, Subramany S, Kuriakose K, Shirazi LF, Romeo F, Shah PK and Mehta JL: Infections, atherosclerosis, and coronary heart disease. Eur Heart J. 38:3195–3201. 2017.PubMed/NCBI View Article : Google Scholar

Dickson BC and Gotlieb AI: Towards understanding acute destabilization of vulnerable atherosclerotic plaques. Cardiovasc Pathol. 12:237–248. 2003.PubMed/NCBI View Article : Google Scholar

Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E and Aukrust P: Atherosclerotic plaque stability-what determines the fate of a plaque? Prog Cardiovasc Dis. 51:183–194. 2008.PubMed/NCBI View Article : Google Scholar

Li B, Xia Y and Hu B: Infection and atherosclerosis: TLR-dependent pathways. Cell Mol Life Sci. 77:2751–2769. 2020.PubMed/NCBI View Article : Google Scholar

Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W and Meyer J: Impact of infectious burden on progression of carotid atherosclerosis. Stroke. 33:2581–2586. 2002.PubMed/NCBI View Article : Google Scholar

Husain K, Hernandez W, Ansari RA and Ferder L: Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem. 6:209–217. 2015.PubMed/NCBI View Article : Google Scholar

Badimon L and Vilahur G: Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 276:618–632. 2014.PubMed/NCBI View Article : Google Scholar

Libby P: The changing landscape of atherosclerosis. Nature. 592:524–533. 2021.PubMed/NCBI View Article : Google Scholar

Krafft C and Christy C: Mycoplasma pneumonia in children and adolescents. Pediatr Rev. 41:12–19. 2020.PubMed/NCBI View Article : Google Scholar

Lewes D, Rainford DJ and Lane WF: Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infections. Br Heart J. 36(924)1974.PubMed/NCBI View Article : Google Scholar

Zhao Y, Ma G and Yang X: HDAC5 promotes Mycoplasma pneumoniae-induced inflammation in macrophages through NF-κB activation. Life Sci. 221:13–19. 2019.PubMed/NCBI View Article : Google Scholar

Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, et al: Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol. 5(100149)2021.PubMed/NCBI View Article : Google Scholar

Buttar HS, Li T and Ravi N: Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 10:229–249. 2005.PubMed/NCBI

Zhu Y, Chunmei L, Paihe D, Jianping W, Xiaowei W and Weihua M: Epidemiological investigation and analysis of Mycoplasma pneumoniae infection. Nanoscie Nanotechnol Lett. 11:424–427. 2019.

Atkinson TP, Balish MF and Waites KB: Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 32:956–973. 2008.PubMed/NCBI View Article : Google Scholar

Guillon A, Arafa EI, Barker KA, Belkina AC, Martin I, Shenoy AT, Wooten AK, Lyon De Ana C, Dai A, Labadorf A, et al: Pneumonia recovery reprograms the alveolar macrophage pool. JCI Insight. 5(e133042)2020.PubMed/NCBI View Article : Google Scholar

Watson A and Wilkinson TMA: Respiratory viral infections in the elderly. Ther Adv Respir Dis. 15(1753466621995050)2021.PubMed/NCBI View Article : Google Scholar

Lv YT, Sun XJ, Chen Y, Ruan T, Xu GP and Huang JA: Epidemic characteristics of Mycoplasma pneumoniae infection: A retrospective analysis of a single center in Suzhou from 2014 to 2020. Ann Transl Med. 10(1123)2022.PubMed/NCBI View Article : Google Scholar

Feldman C and Anderson R: Anderson, Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia. Pneumonia (Nathan). 8(11)2016.PubMed/NCBI View Article : Google Scholar

Lee M and Lee BC: Statins. Stroke Revisited: Dyslipidemia in Stroke. pp77-89, 2021.

Das UN: Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 7(37)2008.PubMed/NCBI View Article : Google Scholar

Alexander DP, Nickman NA, Chhibber A, Stoddard GJ, Biskupiak JE and Munger MA: Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality. Pharmacotherapy. 42:890–897. 2022.PubMed/NCBI View Article : Google Scholar

Bakhle Y: How ACE inhibitors transformed the renin-angiotensin system. Br J Pharmacol. 177:2657–2665. 2020.PubMed/NCBI View Article : Google Scholar

Belova L: Angiotensin II-generating enzymes. Biochemistry (Moscow). 65:1337–1345. 2000.PubMed/NCBI View Article : Google Scholar

Javanmard SH, Heshmat-Ghahdarijani K and Vaseghi G: Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. Infection Control Hosp Epidemiol. 42:118–119. 2021.PubMed/NCBI View Article : Google Scholar

Siragy H: Angiotensin II receptor blockers: Review of the binding characteristics. Am J Cardiol. 84:3–8. 1999.PubMed/NCBI View Article : Google Scholar

Hjermitslev M, Grimm DG, Wehland M, Simonsen U and Krüger M: Azilsartan medoxomil, an angiotensin II receptor antagonist for the treatment of hypertension. Basic Clin Pharmacol Toxicol. 121:225–233. 2017.PubMed/NCBI View Article : Google Scholar

Dasgupta C and Zhang L: Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov Today. 16:22–34. 2011.PubMed/NCBI View Article : Google Scholar

Kobori H, Mori H, Masaki T and Nishiyama A: Angiotensin II blockade and renal protection. Curr Pharm Design. 19:3033–3042. 2013.PubMed/NCBI View Article : Google Scholar

Sibila O, Restrepo MI and Anzueto A: What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents). Infectious Dis Clin. 27:133–147. 2013.PubMed/NCBI View Article : Google Scholar

de Gomensoro E, Del Giudice G and Doherty TM: Challenges in adult vaccination. Ann Med. 50:181–192. 2018.PubMed/NCBI View Article : Google Scholar

Warren-Gash C, Smeeth L and Hayward AC: Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. Lancet Infect Dis. 9:601–610. 2009.PubMed/NCBI View Article : Google Scholar

Mohseni H, Kiran A, Khorshidi R and Rahimi K: Influenza vaccination and risk of hospitalization in patients with heart failure: A self-controlled case series study. Eur Heart J. 38:326–333. 2017.PubMed/NCBI View Article : Google Scholar

Behrouzi B, Bhatt DL, Cannon CP, Vardeny O, Lee DS, Solomon SD and Udell JA: Association of influenza vaccination with cardiovascular risk: A meta-analysis. JAMA Netw Open. 5(e228873)2022.PubMed/NCBI View Article : Google Scholar

Saade EA, Abul Y, McConeghy K, Edward Davidson H, Han L, Joyce N, Canaday DH, Hsueh L, Bosco E and Gravenstein S: High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: Post-hoc analysis of a cluster-randomized trial. Vaccine. 40:6700–6705. 2022.PubMed/NCBI View Article : Google Scholar

Jaiswal V, Ang SP, Lnu K, Ishak A, Pokhrel NB, Chia JE, Hajra A, Biswas M, Matetic A, Dhatt R and Mamas MA: Effect of pneumococcal vaccine on mortality and cardiovascular outcomes: A systematic review and meta-analysis. J Clin Med. 11(3799)2022.PubMed/NCBI View Article : Google Scholar

Mahmood M, Javaid A, Shahid F and Ashfaq UA: Rational design of multimeric based subunit vaccine against Mycoplasma pneumonia: Subtractive proteomics with immunoinformatics framework. Infect Genet Evol. 91(104795)2021.PubMed/NCBI View Article : Google Scholar